CSPC Innovation Pharmaceutical Co., Ltd.

SZSE:300765.SZ

23.56 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q1
Revenue 507.063439.771524.067593.344592.261625.59684.021,077.435509.65592.182447.223383.369341.186350.293357.14284.519345.662331.623355.61296.349306.636311.375342.142338.428284.936315.349301.385247.258247.258268.332268.332
Cost of Revenue 296.774299.45279.298360.866305.683339.52367.327678.176265.447321.991225.956230.614180.709185.345149.449142.831145.937122.856172.574152.157143.856144.356171.473177.392140.795159.301153.884127.696127.696136.495136.495
Gross Profit 210.289140.321244.769232.478286.578286.07316.693399.259244.202270.19221.267152.755160.476164.948207.691141.689199.724208.767183.036144.192162.78167.019170.669161.037144.141156.048147.501119.562119.562131.837131.837
Gross Profit Ratio 0.4150.3190.4670.3920.4840.4570.4630.3710.4790.4560.4950.3980.470.4710.5820.4980.5780.630.5150.4870.5310.5360.4990.4760.5060.4950.4890.4840.4840.4910.491
Reseach & Development Expenses 205.101114.209110.47612.24811.3618.76813.54624.98811.0474.3675.8988.4914.7044.7912.4135.7332.7273.1092.4773.623.7713.0372.6243.1453.072.8622.1741.7951.7956.0486.048
General & Administrative Expenses 38.539-4.99123.708-27.9741.995-4.74517.081-19.01132.461-4.7689.499-16.76124.7-6.31710.55-22.36811.197-6.17212.554-23.31511.099-4.7312.684-17.23811.98915.2348.4396.1136.1139.6529.652
Selling & Marketing Expenses 62.16120.22653.03835.31861.67741.48466.75562.37362.12751.93667.81347.24159.27255.86198.62268.07985.85488.01786.09360.14168.59674.14876.1872.16666.06770.46766.82453.60353.60350.07650.076
SG&A 100.70130.90976.74659.407103.67336.73983.83643.36294.58847.16877.31330.4883.97249.543109.17245.71197.05181.84598.64636.82679.69569.41888.86454.92878.05685.775.26360.50460.50459.90659.906
Other Expenses -46.775-0.6250.629-3.7491.0292.4320.728-0.9390.162-0.362-3.077-7.3840.503-1.009-0.269-0.4380.0513.0262.5573.911-1.26-0.3720.0591.0560.003-0.03-0.1830000
Operating Expenses 259.027145.744194.93871.65593.91577.364103.033126.30792.69470.66685.56562.62972.87973.089113.68187.819103.00493.608106.05282.34585.67775.97596.25691.87374.4986.60480.38564.93964.93965.71265.712
Operating Income -47.487-5.42356.156160.823214.812251.873214.533302.94189.579224.009139.05995.76997.681100.069101.73750.73296.288125.54187.46167.51294.673100.62570.02364.27575.69475.83262.47852.21752.21767.56667.566
Operating Income Ratio -0.094-0.0120.1070.2710.3630.4030.3140.2810.3720.3780.3110.250.2860.2860.2850.1780.2790.3790.2460.2280.3090.3230.2050.190.2660.240.2070.2110.2110.2520.252
Total Other Income Expenses Net -0.40319.4480.62934.7891.0292.4320.728-0.9390.162-0.362-3.077-7.3840.503-1.009-0.269-0.4380.0513.0262.5573.911-1.26-0.3720.0591.0560.003-0.03-0.1831.7791.779-2.14-2.14
Income Before Tax -47.89114.02556.784195.612215.84254.306215.262302.001189.742223.647135.98288.38598.18499.061101.46850.29496.34128.56890.01771.42293.413100.25370.08265.33175.69775.80262.29453.99653.99665.42665.426
Income Before Tax Ratio -0.0940.0320.1080.330.3640.4070.3150.280.3720.3780.3040.2310.2880.2830.2840.1770.2790.3880.2530.2410.3050.3220.2050.1930.2660.240.2070.2180.2180.2440.244
Income Tax Expense 26.98911.79526.82334.56633.13435.43833.33238.32629.37732.0525.00716.10917.08919.41717.947.7918.62522.216.89111.44716.9919.58113.62512.07914.74114.67612.12310.27310.27311.69411.694
Net Income 2.30257.96679.061172.081182.858218.642181.976263.662160.245191.379110.99272.62280.97979.60883.86242.6577.699106.40673.0859.87676.33380.5456.44953.10260.56861.14750.17143.72343.72353.73253.732
Net Income Ratio 0.0050.1320.1510.290.3090.3490.2660.2450.3140.3230.2480.1890.2370.2270.2350.150.2250.3210.2060.2020.2490.2590.1650.1570.2130.1940.1660.1770.1770.20.2
EPS 0.0020.0420.0680.150.160.190.160.240.160.190.10.0620.0690.0810.0850.0360.0790.090.0740.0680.0780.0680.0770.060.0820.0670.0680.0490.0490.0610.061
EPS Diluted 0.0020.0420.0680.150.160.190.160.240.160.190.10.0620.0690.0810.0850.0360.0790.090.0740.0680.0780.0680.0770.060.0820.0670.0680.0490.0490.0610.061
EBITDA -47.87747.08462.017186.036216.208253.761214.097303.515191.137225.918138.722119.01572.773109.48692.26381.91293.165131.83881.39477.95487.26395.95671.01169.30975.40373.43264.69761.65861.65875.75475.754
EBITDA Ratio -0.0940.1070.1180.3140.3650.4060.3130.2820.3750.3820.310.310.2130.3130.2580.2880.270.3980.2290.2630.2850.3080.2080.2050.2650.2330.2150.2490.2490.2820.282